Section I
281 – 290 of 4902
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Bias and precision of SPECT-based 177Lu activity-concentration estimation using a ring-configured solid-state versus a dual-headed anger system
(
- Contribution to journal › Article
-
Mark
Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden : the Obesity and Disease Development Sweden (ODDS) pooled cohort study
(
- Contribution to journal › Article
-
Mark
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE) : a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
(
- Contribution to journal › Article
-
Mark
RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer
(
- Contribution to journal › Article
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
(
- Contribution to journal › Article
-
Mark
Tattoos as a risk factor for malignant lymphoma: a population-based case–control study
(
- Contribution to journal › Article
-
Mark
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE
(
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
- 2023
-
Mark
The implementation of NILS : A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer
(
- Contribution to journal › Article
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Article